Back to results
TerminatedPhase 3

Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression

NCT01093963

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Lindner Center of HOP

Mason, Ohio, United States

View on ClinicalTrials.gov
Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression — TrialFind